Agencourt Bioscience, which supports Sanger, next-generation and hybrid sequencing projects, has bought an Illumina Genome Analyzer II (GAII) for its sequencing suite.
Low library construction input requirements and a variety of kitted applications make the Illumina platform suited for many research projects.
Agencourt Bioscience already uses a 454 Life Sciences Genome Sequencer FLX and an Applied Biosystems Solid in production.
The long reads provided by the 454 Life Sciences GS FLX systems and Titanium reagents are suitable for a variety of scientific applications and are particularly valuable for de novo sequencing projects.
Agencourt Bioscience provides nucleic-acid purification products and genomic services for life-science research.
